Issue link: http://osercommunicationsgroup.uberflip.com/i/1013201
Chain Drugstore Daily 4 3 Saturday, August 25, 2018 Bioceutical Manufacturer Launches New Products Miami-based ScimeraMD, a leading bio- ceutical manufacturer, has announced the launch of two new physician-formulated, natural products that can enhance the immune system and increase energy. The announcement was made by Frederick M. Chaleff, M.D., F.A.C.C, and Chief Executive Officer/Founder of Scimera BioScience, doing business as ScimeraMD. "These new products – Immune MD™ and E2 Energy & Performance™ – have been stringently researched and we're confident that they meet the high criteria of our other products that have been well-received by the marketplace," said Dr. Chaleff. "Clinical studies and independent university research support the efficacy of these products that are available online, at independent pharma- cies and supermarkets nationwide and internationally." ImmuneMD is a physician-formulat- ed product that is comprehensive in maintaining and boosting immune sys- tem functions, according to Dr. Chaleff. The orange-flavored immune booster complex powder can be mixed in water or sprinkled in shakes. The patent-pend- ing product features highly researched immune support ingredients that act syn- ergistically to optimize users' immune systems, health and wellness. "ImmuneMD is designed to provide immune support for travelers, office workers, students, professionals and oth- ers in close contact with people," said Dr. Chaleff. "In addition to these closequar- ter situations, ImmuneMD also delivers year-round immune support for overall health and wellness." The product combines highly absorbable Vitamin C, high-dose chelat- ed zinc, 10 billion CFU of highly researched immuno probiotics, and potent beta glucans such as well-known Wellmune ® +, all ingredients that inde- pendently promote your immune system function. When com- bined, Dr. Chaleff believes that it is extremely comprehen- sive and recommends it to patients on a rou- tine basis. E2 Energy & Performance features the same testing and research guidelines as other Scimera products and has proven to be effective in promoting energy, focus and physical performances. According to Dr. Chaleff, independent clinical studies and university research indicate that users experience a 24 percent immediate increase in muscle performance. The tropical fruit-flavored powder can be mixed in water, drinks, food and popular smoothie shakes. United States Army soldiers, stu- dents, professional athletes and health club members report the effectiveness of this product. About Scimera BioScience ® Scimera Bioscience, doing business as ScimeraMD, develops cutting-edge bio- ceuticals that address car- diovascular, immune sys- tem, bone and joint, gas- trointestinal, respiratory and a wide array of health issues. The team includes physicians, pharmacists, chemists and consumer advocates. The company utilizes the best clinical studies, advanced research and evidence-based data, and strives to promote understanding of disease processes and proactive intervention. Products are made in the USA in an FDA-inspected facility that meets the stringent standards of current Good Manufacturing Practices (GMP) and U.S. Pharmacopeia guidelines. These statements have not been evaluat- ed by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. +Wellmune (WGP) ® is a registered trademark of Kerry Group. For more information, visit booth #4043 or go to www.scimera.com. GERM SHIELD: New Weapons in the Battle Against Infection Medline (owner of CURAD) is dedicated to developing and refining clinical solu- tions to help aid in infection prevention and is continuously evolving to meet the challenges faced by new strains of infec- tious microbes. Among these new advances is the CURAD GERM SHIELD product line that includes: GERM SHIELD Antimicrobial Wound Gel, GERM SHIELD Pre-Surgery Antiseptic Skin Cleanser Kit, and GERM SHIELD 2-Layer Disposable Nitrile Gloves. Each is designed to help prevent infection in specific healthcare situations and everyday first aid. Even minor cuts, scrapes and burns can lead to major risks if not treated properly. For such injuries, CURAD GERM SHIELD Antimicrobial Gel pro- vides many advantages in the treatment of minor wounds. In lab testing, GERM SHIELD Gel has proven to be effective in killing infectious bacteria such as staph, MRSA and E. coli, as well as fun- gus and yeast. It contains an ionized sil- ver antimicrobial that has not been shown to be susceptible to bacterial resistance. GERM SHIELD Gel keeps working up to three days after applica- tion, unlike other products which may lose effectiveness after a few hours. In addition, it's non-stinging, non-staining and provides moisture to the wound to help maintain an optimal healing envi- ronment. With risk of post-surgical infection estimated to be 1 per- cent to 3 percent, pre- vention is of great importance to doctors, facilities and patients. The CURAD GERM SHIELD Pre-Surgery Kit is a complete system to help reduce the risk of post- surgical infection. It includes every- thing needed for two complete cleans- ings, one the night before, and another on the morning of surgery. The GERM SHIELD kit contains 8 ounces of 4% DYNA-HEX CHG (Chlorhexidine Gluconate), the same active ingredient as HIBICLENS ® . Also included are two bathing mitts for use in each cleansing, and a waterproof shower card with easy-to-follow, illustrated instructions. With post-surgical infections account- ing for almost 20 percent of all hospital- acquired infections, it's no wonder facilities are specifying the use of proven CHG antiseptic cleanser like GERM SHIELD to kill body- borne pathogens and inhibit their return. For tough, hands-on protection to tackle a variety of tasks, GERM SHIELD 2-Layer Nitrile Gloves provide performance that has been test- ed to high medical standards for durabil- ity and resistance to many common chemicals. (Please consult OSHA stan- dards before using any glove in contact with hazardous materials). The two lay- ers of nitrile also feature a secure, tex- tured grip and two different colored lay- ers, green and white, to help provide a visual warning to indicate rips or wear. Perfect for caring for people who are sick and contagious; they're also great for many other uses, including cleaning, food prep, painting, automotive, crafts, pet care and more. Market Chat with XIL Consulting An interview with Raymond McCall, President, XIL Consulting. CDD: You've recently joined XIL Consulting as company President. How did you move from pharmacy into the consulting space? RM: I actually started my career as a licensed pharmacist, behind the counter. Which I loved. Over the years, I moved into senior executive roles at companies like Albertsons, CVS and AholdUSA. It was Chuck Kneese's work with XIL that led me to the firm and Susan Lang, the Chief Executive Officer and Founder. XIL was answering big strategy ques- tions for clients: how to expand leverage in the market, how to create and mone- tize new products and services? Their results were so phenomenal, I decided to join the team. CDD: What are the needs in this space? RM: The biggest problem we're seeing is a of lack transparency. You have a sig- nificant knowledge gap between what clients are trying to do strategically, and what's actually happening in the market. Pharmacy is at a crossroads today. We're still defining the space for the con- sumer, which includes cash benefits. The same for PBMs. Aggregation is so over- whelming, people are looking for alterna- tives. And specialty drugs. What do you do when payers and sponsors can't sus- tain their costs? We like these types of complex issues. We tease them apart and come up with tangible solutions that move the industry forward. What will healthcare look like in 2025 and beyond? We get to help define that. CDD: Where is the opportunity for that type of work? RM: Everywhere. It's absolutely every- where. We have worked on multi- billion dollar acquisitions, with Fortune 50 companies on pricing strategies, Fortune 200 companies on what do to with drug rebates, and PSAOs on what do with their value prop. Right now, everybody is looking for a different way to approach the market, because at the end of the day the costs are not sustainable. CDD: In your work with XIL Consulting, how do you set yourself and your team apart? RM: First, we have a deep commitment to our client success. We want our clients to be the most competitive in the market. Part of that is knowledge transfer. We leave them better able to handle new ini- tiatives and challenges, internally. And with every one of our engagements, there has to be an economic outcome for the client. We're always on the lookout for that. Second, our people. We hire very deliberately. You have to have deep, deep knowledge of your busi- ness and be one of the top five at what you do. Third, we're multi-discipli- nary. That means our team brings every perspective to the table. We have knowledge across the medical and drug spend where most firms only offer a single piece. CDD: What's the focus for XIL for 2018? RM: Right now, we're building an ana- lytics platform using blockchain technol- ogy. Next, we're looking to move towards virtual consulting. We're a con- sulting company but we're also a tech- nology company, so we're always look- ing for ways to leverage new tech to the benefit of our clients. We think it's going to be a really great year. For more information, go to www .xilconsulting.com, call 239.249.5902 ext. 714 or email r.mccall@xilang consulting.com.